other material
confidence high
sentiment neutral
materiality 0.35
Elevance Health reaffirms FY2026 adjusted EPS at least $26.75, benefit expense ratio ~90.2%
Elevance Health, Inc.
- Reaffirms FY2026 GAAP EPS guidance at least $19.85, including ~$6.90 net unfavorable items.
- Adjusted shareholders' earnings guidance unchanged at at least $26.75 per diluted share.
- Benefit expense ratio guidance reaffirmed at 90.2% ± 50 basis points.